Pfizer recalls some lots of blood pressure drug due to potential carcinogen Reuters Mar 23, 2022 Pfizer said it has not received any reports of adverse events related to the drug till date
US FDA releases guidance to detect and prevent nitrosamines in drugs EP News Bureau Sep 2, 2020 It recommends steps, including a comprehensive risk assessment strategy and other actions
Accurate, sensitive mass techniques required to identify specific peak of certain nitrosamines Viveka Roychowdhury May 29, 2020 Continuing its investigation into the presence of potential carcinogenic materials in various medicines, on May 28, the US FDA…